Processa Pharmaceuticals Announces Positive Efficacy Results From Preliminary Evaluation of Phase 1B Dose-Escalating Trial With Ngc-Cap in Gastrointestinal Cancer
Processa Pharmaceuticals宣佈通過Ngc-Cap在胃腸癌的1B期劑量遞增試驗的初步評估取得積極的療效結果。
Processa Pharmaceuticals Announces Positive Efficacy Results From Preliminary Evaluation of Phase 1B Dose-Escalating Trial With Ngc-Cap in Gastrointestinal Cancer
Processa Pharmaceuticals宣佈通過Ngc-Cap在胃腸癌的1B期劑量遞增試驗的初步評估取得積極的療效結果。
譯文內容由第三人軟體翻譯。